These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33854470)

  • 1. Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?
    Savini G; Asteggiano C; Paoletti M; Parravicini S; Pezzotti E; Solazzo F; Muzic SI; Santini F; Deligianni X; Gardani A; Germani G; Farina LM; Bergsland N; Gandini Wheeler-Kingshott CAM; Berardinelli A; Bastianello S; Pichiecchio A
    Front Neurol; 2021; 12():613834. PubMed ID: 33854470
    [No Abstract]   [Full Text] [Related]  

  • 2. Multi-parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophy.
    Hooijmans MT; Habets LE; van den Berg-Faay SAM; Froeling M; Asselman FL; Strijkers GJ; Jeneson JAL; Bartels B; Nederveen AJ; van der Pol WL
    NMR Biomed; 2022 Jul; 35(7):e4696. PubMed ID: 35052014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle quantitative MRI in adult SMA patients on nusinersen treatment: a longitudinal study.
    Gallone A; Mazzi F; Bonanno S; Zanin R; Moscatelli M; Aquino D; Maggi L
    Acta Myol; 2022 Jun; 41(2):76-83. PubMed ID: 35832502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot study.
    Otto LAM; Froeling M; van Eijk RPA; Asselman FL; Wadman R; Cuppen I; Hendrikse J; van der Pol WL
    NMR Biomed; 2021 Apr; 34(4):e4473. PubMed ID: 33480130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI.
    Otto LAM; Froeling M; van Eijk RPA; Wadman RI; Cuppen I; van der Woude DR; Bartels B; Asselman FL; Hendrikse J; van der Pol WL
    J Neuromuscul Dis; 2024; 11(1):91-101. PubMed ID: 38073395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3.
    Otto LAM; van der Pol WL; Schlaffke L; Wijngaarde CA; Stam M; Wadman RI; Cuppen I; van Eijk RPA; Asselman FL; Bartels B; van der Woude D; Hendrikse J; Froeling M
    NMR Biomed; 2020 Oct; 33(10):e4357. PubMed ID: 32681555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment for spinal muscular atrophy type I.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD006281. PubMed ID: 31825542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.
    Kokaliaris C; Evans R; Hawkins N; Mahajan A; Scott DA; Sutherland CS; Nam J; Sajeev G
    Adv Ther; 2024 Jun; 41(6):2414-2434. PubMed ID: 38705943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
    Fox D; To TM; Seetasith A; Patel AM; Iannaccone ST
    Adv Ther; 2023 Mar; 40(3):903-919. PubMed ID: 36534265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nusinersen: A Review in 5q Spinal Muscular Atrophy.
    Hoy SM
    CNS Drugs; 2021 Dec; 35(12):1317-1328. PubMed ID: 34850360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative muscle magnetic resonance imaging in limb-girdle muscular dystrophy type R1 (LGMDR1): A prospective longitudinal cohort study.
    Forsting J; Wächter M; Froeling M; Rohm M; Güttsches AK; De Lorenzo A; Südkamp N; Kocabas A; Vorgerd M; Enax-Krumova E; Rehmann R; Schlaffke L
    NMR Biomed; 2024 May; ():e5172. PubMed ID: 38794994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study.
    Sahashi K; Hashizume A; Kuwatsuka Y; Chinen M; Saotome-Nakamura A; Ando M; Katsuno M
    JMIR Res Protoc; 2022 Dec; 11(12):e38878. PubMed ID: 36520510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer).
    Rasoanandrianina H; Grapperon AM; Taso M; Girard OM; Duhamel G; Guye M; Ranjeva JP; Attarian S; Verschueren A; Callot V
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28926131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nusinersen ameliorates motor function and prevents motoneuron Cajal body disassembly and abnormal poly(A) RNA distribution in a SMA mouse model.
    Berciano MT; Puente-Bedia A; Medina-Samamé A; Rodríguez-Rey JC; Calderó J; Lafarga M; Tapia O
    Sci Rep; 2020 Jul; 10(1):10738. PubMed ID: 32612161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring for myelopathic progression with multiparametric quantitative MRI.
    Martin AR; De Leener B; Cohen-Adad J; Kalsi-Ryan S; Cadotte DW; Wilson JR; Tetreault L; Nouri A; Crawley A; Mikulis DJ; Ginsberg H; Massicotte EM; Fehlings MG
    PLoS One; 2018; 13(4):e0195733. PubMed ID: 29664964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular MRI and magnetic resonance neurography in spinal muscular atrophy.
    Huang Y; Chen T; Hu Y; Li Z
    Clin Radiol; 2024 Sep; 79(9):673-680. PubMed ID: 38945793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study.
    Shimizu-Motohashi Y; Chiba E; Mizuno K; Yajima H; Ishiyama A; Takeshita E; Sato N; Oba M; Sasaki M; Ito S; Komaki H
    Brain Dev; 2023 Mar; 45(3):161-170. PubMed ID: 36460551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nusinersen treatment of Spinal Muscular Atrophy Type 1 - results of expanded access programme in Poland.
    Modrzejewska S; Kotulska K; Kopyta I; Grędowska E; Emich-Widera E; Tomaszek K; Paprocka J; Chmielewski D; Pilch J; Pietruszewski J; Lemska A; Zawadzka M; Mazurkiewicz-Bełdzińska M
    Neurol Neurochir Pol; 2021; 55(3):289-294. PubMed ID: 33565602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI correlates of motoneuron loss in SMA.
    Sprenger-Svačina A; Haensch J; Weiss K; Große Hokamp N; Maintz D; Schlamann M; Fink GR; Schloss N; Laukamp K; Wunderlich G; Lehmann HC; Lichtenstein T
    J Neurol; 2023 Jan; 270(1):503-510. PubMed ID: 36180649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis.
    Wendebourg MJ; Weigel M; Weidensteiner C; Sander L; Kesenheimer E; Naumann N; Haas T; Madoerin P; Braun N; Neuwirth C; Weber M; Jahn K; Kappos L; Granziera C; Schweikert K; Sinnreich M; Bieri O; Schlaeger R
    Eur J Neurol; 2024 Jun; 31(6):e16268. PubMed ID: 38465478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.